-
Je něco špatně v tomto záznamu ?
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC
V. Koucký, K. Hladíková, E. Táborská, J. Bouček, M. Grega, R. Špíšek, A. Fialová
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
Grantová podpora
668217
Grantová Agentura, Univerzita Karlova
NLK
PubMed Central
od 1982
ProQuest Central
od 1997-03-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-04-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-03-01 do Před 1 rokem
Public Health Database (ProQuest)
od 1997-03-01 do Před 1 rokem
- MeSH
- biologické markery MeSH
- cytokiny metabolismus MeSH
- dendritické buňky imunologie metabolismus patologie MeSH
- dlaždicobuněčné karcinomy hlavy a krku etiologie metabolismus patologie MeSH
- exprese genu MeSH
- infekce papilomavirem komplikace virologie MeSH
- interferon alfa imunologie metabolismus MeSH
- lidé MeSH
- náchylnost k nemoci MeSH
- nádorové mikroprostředí * imunologie MeSH
- regulační T-lymfocyty imunologie metabolismus MeSH
- studie případů a kontrol MeSH
- T-lymfocyty - podskupiny imunologie metabolismus MeSH
- virová transformace buněk MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024994
- 003
- CZ-PrNML
- 005
- 20220929144812.0
- 007
- ta
- 008
- 211013s2021 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00262-021-02874-y $2 doi
- 035 __
- $a (PubMed)33569630
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Koucký, Vladimír $u , Sotio, Prague, Czech Republic. koucky@sotio.com $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic. koucky@sotio.com
- 245 14
- $a The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC / $c V. Koucký, K. Hladíková, E. Táborská, J. Bouček, M. Grega, R. Špíšek, A. Fialová
- 520 9_
- $a Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a virová transformace buněk $7 D002472
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a dendritické buňky $x imunologie $x metabolismus $x patologie $7 D003713
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a interferon alfa $x imunologie $x metabolismus $7 D016898
- 650 _2
- $a infekce papilomavirem $x komplikace $x virologie $7 D030361
- 650 _2
- $a dlaždicobuněčné karcinomy hlavy a krku $x etiologie $x metabolismus $x patologie $7 D000077195
- 650 _2
- $a T-lymfocyty - podskupiny $x imunologie $x metabolismus $7 D016176
- 650 _2
- $a regulační T-lymfocyty $x imunologie $x metabolismus $7 D050378
- 650 12
- $a nádorové mikroprostředí $x imunologie $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hladíková, Kamila $u , Sotio, Prague, Czech Republic
- 700 1_
- $a Táborská, Eliška $u Sotio, Prague, Czech Republic $7 ola20211133478
- 700 1_
- $a Bouček, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Grega, Marek $u Department of Pathology and Molecular Medicine, Second Medical Faculty, Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Špíšek, Radek $u , Sotio, Prague, Czech Republic
- 700 1_
- $a Fialová, Anna $u , Sotio, Prague, Czech Republic. fialova@sotio.com
- 773 0_
- $w MED00001041 $t Cancer immunology, immunotherapy : CII $x 1432-0851 $g Roč. 70, č. 9 (2021), s. 2545-2557
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33569630 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20220929144806 $b ABA008
- 999 __
- $a ok $b bmc $g 1714163 $s 1145501
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 70 $c 9 $d 2545-2557 $e 20210211 $i 1432-0851 $m Cancer immunology and immunotherapy $n Cancer Immunol Immunother $x MED00001041
- GRA __
- $a 668217 $p Grantová Agentura, Univerzita Karlova
- LZP __
- $a Pubmed-20211013